199 related articles for article (PubMed ID: 34644709)
21. Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus.
Li M; Fan R; Peng X; Huang J; Zou H; Yu X; Yang Y; Shi X; Ma D
Front Endocrinol (Lausanne); 2021; 12():695750. PubMed ID: 34603198
[TBL] [Abstract][Full Text] [Related]
22. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
[TBL] [Abstract][Full Text] [Related]
23. Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study.
Liu Q; Wang M; Xu T; Liang W; Yang F
J Clin Lab Anal; 2022 Feb; 36(2):e24210. PubMed ID: 34964177
[TBL] [Abstract][Full Text] [Related]
24. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
[TBL] [Abstract][Full Text] [Related]
25. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
[TBL] [Abstract][Full Text] [Related]
26. The changing features of serum adropin, copeptin, neprilysin and chitotriosidase which are associated with vascular endothelial function in type 2 diabetic retinopathy patients.
Li B; Li N; Guo S; Zhang M; Li J; Zhai N; Wang H; Zhang Y
J Diabetes Complications; 2020 Nov; 34(11):107686. PubMed ID: 32768333
[TBL] [Abstract][Full Text] [Related]
27. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
[TBL] [Abstract][Full Text] [Related]
28. Serum LncRNA PANDAR may Act as a Novel Serum Biomarker of Diabetic Nephropathy in Patients with Type 2 Diabetes.
Zhao C; Hu J; Wang Z; Cao ZY; Wang L
Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538054
[TBL] [Abstract][Full Text] [Related]
29. Serum osteoinductive factor is associated with microalbuminuria and diabetic nephropathy in type 2 diabetes.
Wei W; Tu M; Huang R; Chen T
Medicine (Baltimore); 2018 Aug; 97(31):e11759. PubMed ID: 30075597
[TBL] [Abstract][Full Text] [Related]
30. Brachial-Ankle Pulse Wave Velocity as a Novel Modality for Detecting Early Diabetic Nephropathy in Type 2 Diabetes Patients.
Zhang X; Bai R; Zou L; Zong J; Qin Y; Wang Y
J Diabetes Res; 2021; 2021():8862573. PubMed ID: 33628837
[TBL] [Abstract][Full Text] [Related]
31. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial.
Tan SMQ; Chiew Y; Ahmad B; Kadir KA
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227659
[TBL] [Abstract][Full Text] [Related]
32. FABP1 and FABP2 as markers of diabetic nephropathy.
Tsai IT; Wu CC; Hung WC; Lee TL; Hsuan CF; Wei CT; Lu YC; Yu TH; Chung FM; Lee YJ; Wang CP
Int J Med Sci; 2020; 17(15):2338-2345. PubMed ID: 32922199
[No Abstract] [Full Text] [Related]
33. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy.
Sueud T; Hadi NR; Abdulameer R; Jamil DA; Al-Aubaidy HA
Diabetes Metab Syndr; 2019; 13(1):564-568. PubMed ID: 30641767
[TBL] [Abstract][Full Text] [Related]
34. Relationship between BNP level and renal function in diabetic nephropathy with microalbuminuria.
Seki N; Nishimura M; Matsumoto T; Fukazawa M; Kenmochi T
J Diabetes Complications; 2013; 27(1):92-7. PubMed ID: 22885249
[TBL] [Abstract][Full Text] [Related]
35. Hemorheological Approach for Early Detection of Chronic Kidney Disease and Diabetic Nephropathy in Type 2 Diabetes.
Lee S; Lee MY; Nam JS; Kang S; Park JS; Shin S; Ahn CW; Kim KR
Diabetes Technol Ther; 2015 Nov; 17(11):808-15. PubMed ID: 26214546
[TBL] [Abstract][Full Text] [Related]
36. Circulating Expression Level of LncRNA Malat1 in Diabetic Kidney Disease Patients and Its Clinical Significance.
Zhou LJ; Yang DW; Ou LN; Guo XR; Wu BL
J Diabetes Res; 2020; 2020():4729019. PubMed ID: 32832561
[TBL] [Abstract][Full Text] [Related]
37. Serum VEGF as a predictive marker of glycemic control and diabetic nephropathy in Chinese older adults with type 2 diabetes mellitus.
Jiang Y; Li J; Zhang J; Chen S
Front Endocrinol (Lausanne); 2023; 14():1274025. PubMed ID: 38075072
[TBL] [Abstract][Full Text] [Related]
38. Changes in Serum Nampt Levels and Its Significances in Diabetic Nephropathy Patients-The Potential Role of Nampt in T2DM with Diabetic Nephropathy.
Ma X; An L; Wang Q
Endocr Metab Immune Disord Drug Targets; 2017; 17(2):114-124. PubMed ID: 28699485
[TBL] [Abstract][Full Text] [Related]
39. Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients.
Wu L; Fang J; Chen L; Zhao Z; Luo Y; Lin C; Fan L
Clin Chem Lab Med; 2014 May; 52(5):751-8. PubMed ID: 24323892
[TBL] [Abstract][Full Text] [Related]
40. E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition.
El-Dawla NMQ; Sallam AM; El-Hefnawy MH; El-Mesallamy HO
Clin Exp Nephrol; 2019 Aug; 23(8):1050-1057. PubMed ID: 31104272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
